Yasuo Terauchi
#161,756
Most Influential Person Now
Researcher
Yasuo Terauchi's AcademicInfluence.com Rankings
Yasuo Terauchicomputer-science Degrees
Computer Science
#9370
World Rank
#9843
Historical Rank
Computational Linguistics
#2251
World Rank
#2274
Historical Rank
Machine Learning
#4081
World Rank
#4130
Historical Rank
Artificial Intelligence
#4421
World Rank
#4482
Historical Rank
Download Badge
Computer Science
Yasuo Terauchi's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yasuo Terauchi Influential?
(Suggest an Edit or Addition)Yasuo Terauchi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (2001) (4863)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (2003) (3033)
- Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* (2002) (1382)
- PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance (1999) (1243)
- Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 (1994) (1071)
- Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* (2003) (945)
- PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. (2004) (834)
- Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. (2007) (776)
- PI3K-mediated negative feedback regulation of IL-12 production in DCs (2002) (609)
- The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* (2001) (593)
- PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. (1999) (536)
- Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. (2000) (532)
- Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. (1999) (510)
- Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. (1999) (456)
- Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis (2013) (430)
- Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase (1999) (428)
- Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. (2011) (386)
- Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity* (2004) (384)
- Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. (2007) (329)
- Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways* (2006) (322)
- Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways (2006) (295)
- Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. (2001) (284)
- The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. (2001) (282)
- Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. (2000) (264)
- High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH (2007) (260)
- Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. (2004) (240)
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice (2011) (240)
- Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. (2007) (222)
- Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. (1995) (221)
- Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury (2001) (218)
- Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. (2008) (216)
- Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice (2002) (210)
- Molecular Mechanism of Insulin Resistance and Obesity (2003) (202)
- Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation (2001) (198)
- Peroxisome Proliferator-Activated Receptor Gamma Agonist Ligands Stimulate a Th2 Cytokine Response and Prevent Acute Colitis (2002) (176)
- Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study (2014) (169)
- Involvement of p85 in p53-dependent apoptotic response to oxidative stress (1998) (167)
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes (2019) (165)
- Relationship between urinary sodium excretion and pioglitazone‐induced edema (2010) (161)
- PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction (2003) (155)
- Lessons from Mouse Models of High-Fat Diet-Induced NAFLD (2013) (153)
- Peroxisome Proliferator-activated Receptor γ-mediated Regulation of Neural Stem Cell Proliferation and Differentiation* (2006) (146)
- Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. (2003) (145)
- Serum ferritin is associated with visceral fat area and subcutaneous fat area. (2005) (140)
- Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. (1997) (140)
- Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts (2002) (139)
- Increased Expression of the Sterol Regulatory Element-binding Protein-1 Gene in Insulin Receptor Substrate-2−/−Mouse Liver* (2001) (138)
- Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. (2007) (133)
- Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study (2010) (131)
- Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. (2001) (129)
- Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus. (2011) (121)
- New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2) (2016) (105)
- Ethidium Bromide-induced Inhibition of Mitochondrial Gene Transcription Suppresses Glucose-stimulated Insulin Release in the Mouse Pancreatic β-Cell Line βHC9* (1998) (104)
- Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. (2001) (104)
- Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus. (2008) (103)
- Lack of Insulin Receptor Substrate‐2 Causes Progressive Neointima Formation in Response to Vessel Injury (2003) (96)
- Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet. (2004) (94)
- Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation. (2003) (92)
- Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage (2007) (88)
- Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. (2005) (85)
- Distinct effects of PPARγ insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells (2005) (85)
- Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. (2009) (84)
- Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients (2007) (82)
- Ghrelin improves renal function in mice with ischemic acute renal failure. (2005) (80)
- Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. (2005) (77)
- Present status of clinical deployment of glucokinase activators (2014) (75)
- Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials (2014) (74)
- Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats (2007) (73)
- A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. (2004) (72)
- Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial (2014) (71)
- Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency* (2004) (67)
- The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes. (2012) (66)
- Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca2+] elevation signals (2002) (66)
- Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. (2006) (65)
- NADH Shuttle System Regulates KATPChannel-dependent Pathway and Steps Distal to Cytosolic Ca2+ Concentration Elevation in Glucose-induced Insulin Secretion* (1999) (63)
- Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. (2005) (63)
- Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. (2006) (61)
- Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. (2008) (61)
- Both Insulin Signaling Defects in the Liver and Obesity Contribute to Insulin Resistance and Cause Diabetes in Irs2–/– Mice* (2004) (60)
- Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes (2017) (60)
- Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity (2016) (59)
- The role of PPAR? in high-fat diet-induced obesity and insulin resistance (2002) (58)
- Genetic manipulations of fatty acid metabolism in beta-cells are associated with dysregulated insulin secretion. (2002) (58)
- Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes. (2000) (57)
- Expression of DGAT2 in White Adipose Tissue Is Regulated by Central Leptin Action* (2005) (57)
- Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. (2013) (55)
- Glucokinase Activation Ameliorates ER Stress–Induced Apoptosis in Pancreatic β-Cells (2013) (54)
- Sonographic evaluation of visceral fat by measuring para‐ and perirenal fat (2008) (53)
- Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes* (2011) (53)
- Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. (2010) (53)
- Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways* (2009) (53)
- Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database (2018) (52)
- Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass. (2009) (50)
- Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients (2012) (49)
- Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men. (2010) (48)
- Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes (2016) (47)
- Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion. (2004) (47)
- Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals. (2002) (46)
- Adrenomedullin augments collateral development in response to acute ischemia. (2003) (46)
- Efficacy and Safety of Empagliflozin Monotherapy for 52 Weeks in Japanese Patients with Type 2 Diabetes: A Randomized, Double-Blind, Parallel-Group Study (2015) (45)
- Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. (2011) (45)
- Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice (1998) (44)
- Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA) (2018) (43)
- Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice (2016) (43)
- Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. (2007) (43)
- Congener-specific polychlorinated biphenyls and the prevalence of diabetes in the Saku Control Obesity Program (SCOP). (2011) (43)
- Crucial role of insulin receptor substrate‐2 in compensatory β‐cell hyperplasia in response to high fat diet–induced insulin resistance (2008) (43)
- beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. (2000) (42)
- Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study (2016) (41)
- Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance (2012) (41)
- The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus. (2009) (41)
- Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients (2012) (40)
- Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin (2012) (40)
- Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study. (2014) (38)
- Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study (2018) (38)
- Low‐molecular‐weight adiponectin and high‐molecular‐weight adiponectin levels in relation to diabetes (2014) (38)
- Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients. (2010) (38)
- Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetes. (2017) (38)
- Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (2015) (37)
- Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. (2012) (36)
- Insulin Resistance and Growth Retardation in Mice Lacking Insulin Receptor Substrate‐1 and Identification of Insulin Receptor Substrate‐2 (1996) (35)
- Deficiency of Insulin Receptor Substrate‐1 Impairs Skeletal Growth Through Early Closure of Epiphyseal Cartilage (2003) (35)
- Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study (2015) (34)
- Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study (2012) (34)
- Germ-line contribution of embryonic stem cells in chimeric mice: influence of karyotype and in vitro differentiation ability. (1997) (33)
- Role of phosphoinositide 3-kinase signaling in mast cells: new insights from knockout mouse studies (2003) (33)
- Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions (2012) (33)
- Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus (2014) (32)
- Pdx1 Expression in Irs2-deficient Mouse β-Cells Is Regulated in a Strain-dependent Manner* (2003) (32)
- Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c. (2010) (31)
- The role of PPARgamma in high-fat diet-induced obesity and insulin resistance. (2002) (31)
- Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (the J-PREDICT study): rationale, study design, and clinical characteristics of 1269 patients (2011) (31)
- Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests. (2011) (31)
- Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice. (2014) (30)
- Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the COMPASS randomized controlled trial (2013) (30)
- Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study. (2010) (30)
- Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J‐STEP/INS): Results of a 16‐week randomized, double‐blind, placebo‐controlled multicentre trial (2017) (30)
- Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution (2015) (30)
- Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study (2016) (30)
- Impact of Genetic Background and Ablation of Insulin Receptor Substrate (IRS)-3 on IRS-2 Knock-out Mice* (2003) (29)
- Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model (2015) (29)
- Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients. (2007) (28)
- Significant association of serum albumin with severity of retinopathy and neuropathy, in addition to that of nephropathy, in Japanese type 2 diabetic patients. (2008) (28)
- The role of PPARγ as a thrifty gene both in mice and humans (2000) (27)
- A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial. (2015) (27)
- Signaling between pancreatic β cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation (2018) (26)
- Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study (2016) (26)
- A newer conversion equation for the correlation between HbA1c and glycated albumin. (2014) (26)
- Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension). (2017) (26)
- Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylation. (2013) (25)
- Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry. (2018) (25)
- Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. (2006) (25)
- β-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in mice. (2014) (25)
- Serum adiponectin and insulin secretion: A direct or inverse association? (2018) (24)
- Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages (2018) (24)
- Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity. (2018) (24)
- Pancreatic β-Cell-specific Targeted Disruption of Glucokinase Gene (1995) (24)
- Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men. (2010) (23)
- Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study) (2019) (23)
- Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study (2016) (23)
- Peroxisome Proliferator-Activated Receptor γ (PPARγ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway (2008) (23)
- Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus. (2019) (22)
- Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. (2008) (22)
- Analysis of the Pancreatic β Cell in the Mouse with Targeted Disruption of the Pancreatic β Cell-Specific Glucokinase Gene (1996) (22)
- Subcellular localization of insulin receptor substrate family proteins associated with phosphatidylinositol 3-kinase activity and alterations in lipolysis in primary mouse adipocytes from IRS-1 null mice. (2001) (22)
- Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. (2008) (21)
- Long‐term safety and efficacy of tofogliflozin as add‐on to insulin in patients with type 2 diabetes: Results from a 52‐week, multicentre, randomized, double‐blind, open‐label extension, Phase 4 study in Japan (J‐STEP/INS) (2018) (21)
- Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. (2014) (21)
- Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START‐J trial) (2017) (21)
- Effects of metformin on compensatory pancreatic β-cell hyperplasia in mice fed a high-fat diet. (2017) (21)
- Effects of liraglutide on β-cell-specific glucokinase-deficient neonatal mice. (2012) (21)
- Critical role of class IA PI3K for c-Rel expression in B lymphocytes. (2009) (21)
- Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase. (2004) (21)
- Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet. (2012) (20)
- Antibody-mediated insulin resistance treated by cessation of insulin administration. (2000) (20)
- Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance (2015) (20)
- Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: a pilot study (2015) (20)
- Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study (2019) (19)
- Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. (2019) (19)
- Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes (2013) (19)
- Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases (2015) (19)
- ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling. (2003) (19)
- Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial (2017) (19)
- The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk (2007) (19)
- A Common Susceptibility Gene for Type 2 Diabetes Is Associated with Drug Response to a DPP-4 Inhibitor: Pharmacogenomic Cohort in Okinawa Japan (2016) (18)
- Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese patients. (2011) (18)
- Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan (2021) (18)
- DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acid (2016) (18)
- Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (2018) (18)
- Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance (2011) (17)
- Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway (2020) (17)
- Problems in diagnosing atypical Gitelman’s syndrome presenting with normomagnesaemia (2010) (17)
- Effect and Safety of Oral Semaglutide Monotherapy in Type 2 Diabetes—PIONEER 1 Trial (2018) (17)
- Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in db/db Mice (2021) (16)
- Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. (2016) (16)
- A novel initial codon mutation of the thiazide-sensitive Na-Cl cotransporter gene in a Japanese patient with Gitelman's syndrome. (2008) (16)
- Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. (2008) (16)
- Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes. (2012) (16)
- Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model. (2016) (16)
- The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial (2016) (16)
- Effect of dehydroepiandrosterone on atherosclerosis in apolipoprotein E-deficient mice. (2009) (16)
- Dietary glycemic index and glycemic load in relation to HbA1c in Japanese obese adults: a cross-sectional analysis of the Saku Control Obesity Program (2012) (15)
- Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men. (2007) (15)
- Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin. (2011) (15)
- Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models. (2002) (15)
- Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus (2018) (15)
- Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c<7% (2013) (15)
- Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26‐week, open‐label, multicentre study: The LixiLan JP‐O2 randomized clinical trial (2020) (14)
- Aging-like physiological changes in the skin of Japanese obese diabetic patients (2018) (14)
- Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study. (2020) (14)
- Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid (2013) (14)
- Imeglimin ameliorates β-cell apoptosis by modulating the endoplasmic reticulum homeostasis pathway. (2021) (14)
- Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin‐changing study intending to gain patients' insights into insulin treatment with patient‐reported health outcomes in actual clinical treatments (INSIGHTs) study (2013) (13)
- Decreased insulin secretion and accumulation of triglyceride in beta cells overexpressing a dominant-negative form of AMP-activated protein kinase. (2010) (13)
- Comparison of pre‐ vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients (2008) (13)
- Effect of long‐term treatment with a small‐molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function (2011) (13)
- Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine. (2008) (13)
- [The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism]. (2003) (13)
- Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: A multicenter study (2018) (13)
- Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study. (2014) (13)
- - Cell Glucokinase Deficiency and Hyperglycemia Are Associated With Reduced Islet Amyloid Deposition in a Mouse Model of Type 2 Diabetes (2000) (13)
- Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study (2018) (12)
- Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study. (2015) (12)
- corrigendum: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (2004) (12)
- Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway. (2008) (12)
- Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes. (2015) (12)
- The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice. (2018) (12)
- Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men. (2013) (12)
- Modification of a simple clinical scoring system as a diagnostic screening tool for non‐alcoholic steatohepatitis in Japanese patients with non‐alcoholic fatty liver disease (2013) (12)
- Sonographic assessment of fatty liver infiltration using the measurement of para‐ and perirenal fat thickness (2010) (12)
- Indicators of the need for insulin treatment and the effect of treatment for gestational diabetes on pregnancy outcomes in Japan. (2016) (12)
- Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes? (2021) (12)
- Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1−/−, and IRS2−/− male mice fed a high-fat diet (2016) (12)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice. (2009) (11)
- Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes (2018) (11)
- The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study (2015) (11)
- Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross‐sectional survey of 15,652 patients (2012) (11)
- Reduction in Adiposity, β-Cell Function, Insulin Sensitivity, and Cardiovascular Risk Factors: A Prospective Study among Japanese with Obesity (2013) (11)
- Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus (2017) (11)
- Impact of glucose tolerance on the severity of non‐alcoholic steatohepatitis (2011) (11)
- Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin/T Cell Factor (TCF) Pathway in the Mouse Intestine (2008) (11)
- Melanophilin Accelerates Insulin Granule Fusion without Predocking to the Plasma Membrane (2020) (10)
- Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. (2016) (10)
- Humanistic and economic burden of cardiovascular disease related comorbidities and hypoglycaemia among patients with type 2 diabetes in Japan. (2019) (10)
- Validity of Diabetes Self-Reports in the Saku Diabetes Study (2013) (10)
- Differential regulation of gene expression and insulin-induced activation of phosphodiesterase 3B in adipocytes of lean insulin-resistant IRS-1 (-/-) mice. (2002) (10)
- Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels. (2014) (10)
- Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones. (2019) (10)
- Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes (2016) (10)
- The role of PPARgamma as a thrifty gene both in mice and humans. (2000) (10)
- Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study (2015) (10)
- Impact of underlying diabetes and presence of lung cavities on treatment outcomes in patients with pulmonary tuberculosis (2014) (10)
- Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes. (2016) (9)
- Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906 (2017) (9)
- Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance. (2009) (9)
- The role of PPARg in high-fat diet-induced obesity and insulin resistance (2002) (9)
- Efficacy and safety of the G protein‐coupled receptor 119 agonist DS‐8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo‐controlled study (2018) (9)
- The beneficial effects of a muscarinic agonist on pancreatic β-cells (2019) (9)
- Peroxisome proliferator-activated receptors and insulin secretion. (2005) (9)
- Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects (2020) (9)
- Pituitary abscess with panhypopituitarism showing T1 signal hyperintensity of the marginal pituitary area: a non-invasive differential diagnosis of pituitary abscess and pituitary apoplexy. (2009) (9)
- Drug-induced hyperglycemia in the Japanese Adverse Drug Event Report database: association of evelolimus use with diabetes. (2019) (9)
- Pravastatin potentiates increases in serum adiponectin concentration in dyslipidemic patients receiving thiazolidinedione: the DOLPHIN study. (2010) (9)
- Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients? (2014) (9)
- Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia. (2011) (8)
- Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study. (2019) (8)
- Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials (2022) (8)
- Role of IRS and PHIP on insulin-induced tyrosine phosphorylation and distribution of IRS proteins. (2007) (8)
- The role of phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract. (2005) (8)
- Insulin Resistance Syndrome in Mice Deficient in Insulin Receptor Substrate‐1 (1997) (8)
- G protein‐coupled receptor 119 agonist DS‐8500a effects on pancreatic β‐cells in Japanese type 2 diabetes mellitus patients (2018) (8)
- Randomized controlled trial of single‐agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study (2011) (8)
- [Glucokinase activators]. (2012) (8)
- [PPAR and diabetes]. (2005) (8)
- Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial (2015) (8)
- Evaluation of organ-specific glucose metabolism by 18F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance (2011) (7)
- PREVALENCE OF OBSTRUCTIVE SLEEP APNEA DETERMINED BY THE WATCHPAT IN NONOBESE JAPANESE PATIENTS WITH POOR GLUCOSE CONTROL AND TYPE 2 DIABETES. (2019) (7)
- Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes (2021) (7)
- The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus (2019) (7)
- Serum Quantitative Proteomic Analysis Reveals Soluble EGFR To Be a Marker of Insulin Resistance in Male Mice and Humans (2017) (7)
- Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open‐label, multicenter study (2017) (7)
- Factors associated with the glucose-lowering effect of vildagliptin identified from the results of the oral glucose tolerance test in Japanese patients with type 2 diabetes. (2013) (7)
- A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes (2018) (7)
- Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study (2020) (7)
- Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene. (1996) (7)
- Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets (2017) (7)
- Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study (2019) (7)
- The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling (2021) (6)
- Dietary survey in Japanese patients with type 2 diabetes and the influence of dietary carbohydrate on glycated hemoglobin: The Sleep and Food Registry in Kanagawa study (2018) (6)
- Self-injection of insulin using appropriate supportive devices in handicapped subjects with diabetes. (2010) (6)
- Reduction of phosphodiesterase 3B gene expression in peroxisome proliferator‐activated receptor γ (+/−) mice independent of adipocyte size (2003) (6)
- Proinsulin is sensitive to reflect glucose intolerance (2019) (6)
- A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes (2017) (6)
- Newer perspective on the coupling between glucose-mediated signaling and β-cell functionality. (2019) (6)
- Plasminogen activator inhibitor-1 is associated with renal dysfunction independent of BMI and serum lipid levels in patients with type 2 diabetes. (2012) (6)
- Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a-day treatment with α-glucosidase inhibitors (2013) (6)
- Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease. (2014) (6)
- [Treatment of NASH: nutritional counseling and physical exercise]. (2006) (6)
- Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes (2020) (6)
- Zyxin modulates the transmigration of Haemophilus influenzae to the central nervous system (2014) (5)
- Selective and sequential loss of transcriptional factors: A hallmark of β‐cell failure in type 2 diabetes? (2014) (5)
- Effect of liraglutide on lipids in patients with type 2 diabetes: a pilot study. (2020) (5)
- AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration (2013) (5)
- PI 3 K and Btk differentially regulate B cell antigen receptor-mediated signal transduction (2003) (5)
- Efficacy of switching from insulin glargine to insulin degludec in patients with type 1 diabetes: a 16-week retrospective study (2017) (5)
- Cross‐sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper (2011) (5)
- Effect of Switching from Sulphonylurea to Repaglinide Twice or Three Times Daily for 4 Months on Glycemic Control in Japanese Patients with Type 2 Diabetes. (2016) (5)
- Effect of Caloric Intake 25 or 30 kcal/kg/day on the Glycemic Control in Obese Patients With Type 2 Diabetes (2013) (5)
- Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: A randomized non‐inferior test (2015) (5)
- Causes of death and estimated life expectancy among people with diabetes: A retrospective cohort study in a diabetes clinic (2019) (5)
- Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes (2016) (5)
- Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance (2005) (5)
- The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes (2021) (5)
- Development and progression of retinopathy after inpatient management of diabetes. (2006) (5)
- Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease (2021) (5)
- Cluster‐randomized trial to improve the quality of diabetes management: The study for the efficacy assessment of the standard diabetes manual (SEAS‐DM) (2016) (5)
- Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus. (2013) (5)
- Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways (2016) (5)
- Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials (2021) (4)
- Effect of Acarbose Therapy Once or Twice a Day on Glycemic Control in Japanese Patients with Type 2 Diabetes (2012) (4)
- Potential linkage between dipeptidyl peptidase‐4 inhibitor use and the risk of pancreatitis/pancreatic cancer (2019) (4)
- [Current status of clinical development of novel anti-diabetic drugs]. (2015) (4)
- Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study (2017) (4)
- Risk of Future Diabetes in Japanese People with High-normal Fasting Plasma Glucose Levels: A 4-Year Follow-up Study. (2016) (4)
- Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice (2021) (4)
- Comparison of Plasma Glucose and Gut Hormone Levels Between Drinking Enteral Formula Over a Period of 5 and 20 Minutes in Japanese Patients With Type 2 Diabetes: A Pilot Study (2016) (4)
- Comparison of plasma active glucagon-like peptide-1 (GLP-1) levels assayed with or without plasma extraction in non-diabetic men. (2012) (4)
- Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study (2019) (4)
- Benefits of the fixed‐ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trials (2020) (4)
- 2130-P: Imeglimin Modulated ER Stress to Prevent ß-Cell Apoptosis Induced by High Glucose or Thapsigargin (2019) (4)
- Effectiveness of repeated intragastric balloon therapy in a morbidly obese Japanese patient. (2011) (3)
- Peroxisome Proliferator-activated Receptor -mediated Regulation of Neural Stem Cell Proliferation (2006) (3)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Glucose‐ or insulin resistance‐mediated β‐cell replication: PKCζ integrates the proliferative signaling (2016) (3)
- Comparative study of effectiveness of multiple-daily injections of insulin versus twice-daily injections of biphasic insulin in patients with type 2 diabetes. (2009) (3)
- Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial (2017) (3)
- Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease (2021) (3)
- Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study (2019) (3)
- Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes ( ASSET-K 1 ) to a target of HbA 1 c < 7 % (3)
- Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome (2017) (3)
- Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial (2020) (3)
- [PPARgamma and metabolic syndrome]. (2007) (3)
- Glucokinase is required for high‐starch diet‐induced β‐cell mass expansion in mice (2021) (3)
- Uncoupling protein 2 and aldolase B impact insulin release by modulating mitochondrial function and Ca2+ release from the ER (2022) (3)
- Predicting the ability of elderly diabetes patients to acquire the insulin self‐injection technique based on the number of animal names recalled (2017) (3)
- Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study (2020) (3)
- Efficacy and safety of saxagliptin for the treatment of type 2 diabetes mellitus (2020) (3)
- Colestimide improves glycemic control via hepatic glucose production in db/db mice. (2014) (3)
- A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg (2022) (2)
- Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study (2017) (2)
- An evaluation of canagliflozin for the treatment of type 2 diabetes: an update (2021) (2)
- Impaired insulin secretion and related factors in East Asian individuals (2021) (2)
- PO193 COMPARATIVE STUDY OF SITAGLIPTIN, VILDAGLIPTIN AND ALOGLIPTIN IN JAPANESE TYPE 2 DIABETIC PATIENTS: THE COSVA RANDOMIZED CONTROLLED TRIAL (2014) (2)
- A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once‐daily injection in patients with well‐controlled type 2 diabetes (2015) (2)
- The PREDICTIVETM Study: a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes—data from the Japan cohort (2012) (2)
- Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance (2017) (2)
- Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure (2020) (2)
- Evidence of brain atrophy detected on magnetic resonance imaging is associated with failure of acquisition of the ability for insulin self-injection. (2014) (2)
- 1573-P: Inverse Association between Serum High-Molecular-Weight Adiponectin Level and Proinsulin Level in a General Japanese Population: DOSANCO Health Study (2020) (2)
- Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use (2018) (2)
- Lifestyle monitoring with the use of an earphone-type thermometer, an ambulatory blood pressure monitoring and a new wristwatch-type pulsimeter with accelerometer (2014) (2)
- Effects of 1‐year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes (2021) (2)
- A Caution in the use of the NAFIC Scoring System as a Diagnostic Screening Tool for Nonalcoholic Steatohepatitis (2014) (2)
- Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice (2019) (2)
- Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study (2018) (2)
- Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor (2020) (2)
- The efficacy and safety of luseogliflozin and sitagliptin depending on the sequence of administration in patients with type 2 diabetes mellitus: a randomized controlled pilot study (2019) (2)
- Role of insulin receptor substrate‐1 for diethylnitrosamine plus high‐fat diet‐induced hepatic tumorigenesis in mice (2013) (2)
- [Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione]. (2010) (2)
- Inverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population: The Dynamics of Lifestyle and Neighborhood Community on Health Study (2020) (2)
- Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study (2020) (1)
- Female Preponderance in the Discordant Association between Retinopathy and Nephropathy in Patients with Type 2 Diabetes Mellitus (2011) (1)
- Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function (2022) (1)
- Molecular Pathogenesis of Type 2 Diabetes Mellitus and Obesity in Knockout Mice Models (2000) (1)
- [Gene targeting approaches for diabetes research]. (2005) (1)
- Efficacy of education on injection technique for patients diagnosed with diabetes with lipohypertrophy: systematic review and meta-analysis (2022) (1)
- Correction to: A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes (2018) (1)
- Add-On Sitagliptin Therapy for Insulin-Treated Type 2 Diabetes: An Analysis of Hemoglobin A1c and Other Variables Using ASSIST-K Follow-Up Data (2018) (1)
- The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study (2022) (1)
- Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitus (2014) (1)
- Using miglitol at 30 min before meal is effective in hyperinsulinemic hypoglycemia after a total gastrectomy. (2014) (1)
- E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance (2022) (1)
- Efficacy and safety of insulin degludec U 100 and insulin glargine U 100 in combination with mealtime bolus insulin in hospitalized patients with type 2 diabetes : an open-label , randomized controlled study (2019) (1)
- Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study) (2020) (1)
- Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study). (2020) (1)
- Efficacy of the Self-management Support System DialBetesPlus for Diabetic Kidney Disease: Protocol for a Randomized Controlled Trial (2021) (1)
- Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study) (2020) (1)
- Are current SGLT2 Inhibitors efficacious treatment options for Type 1 diabetes? (2021) (1)
- Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population (2021) (1)
- Review for "Recent Developments in GLP‐1RA therapy: A Review of The Latest Evidence of Efficacy and Safety and Differences Within The Class" (2021) (1)
- [New diabetes mellitus models: gene targeting]. (1998) (1)
- A randomized controlled trial of a structured program combining aerobic and resistance exercise for adults with type 2 diabetes in Japan (2021) (1)
- Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism. (2017) (1)
- Comparison of the Effect of Empagliflozin and Glimepiride on the Endothelial Function in Patients with Type 2 Diabetes—A Randomized Study (2018) (1)
- A cross-sectional study of the relationship between quality of life and sleep quality in Japanese patients with type 1 diabetes mellitus. (2021) (1)
- [Glucokinase knockout mice]. (1998) (1)
- [Insulin receptor substrate (IRS)]. (2005) (1)
- Effects of Liraglutide on (cid:1) -Cell-Specific Glucokinase-Deficient Neonatal Mice (2012) (1)
- [Insulin receptor substrate (IRS)]. (2010) (1)
- Pathogen-induced systemic plant signal triggers DNA rearrangements (2003) (1)
- Abdominal aortic calcification is associated with Fibrosis‐4 index and low body mass index in type 2 diabetes patients: A retrospective cross‐sectional study (2022) (1)
- Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan (2022) (1)
- Efficacy and safety comparison of sitagliptin and glimepiride in elderly Japanese patients with type 2 diabetes: START-J (2016) (1)
- [Non-islet cell tumor hypoglycemia (NICTH)]. (2006) (1)
- [IRS-1 knockout mouse]. (1998) (1)
- Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study (2022) (1)
- Aging may Affect Insulin Action Independent of Adiposity in Non-Diabetic Subjects. (2016) (1)
- Evaluation of unmet medical need among Japanese patients with type 2 diabetes mellitus and efficacy of Lixisenatide treatment among Asian type 2 diabetes mellitus patients. (2016) (1)
- Diagnostic accuracy of home sleep apnea testing using peripheral arterial tonometry for sleep apnea: A systematic review and meta‐analysis (2022) (1)
- Abstract 13782: Effects of Serum Eicosapentaenoic Acid on Coronary Flow Reserve Evaluated by Phase Contrast Cine Magnetic Resonance Imaging in Patients with Coronary Artery Disease (2012) (1)
- The association of cardiac function, structure, and glycemic control in patients with old myocardial infarction: a study using cardiac magnetic resonance (2017) (1)
- Recurrent Subacute Thyroiditis in a Patient With Human Leukocyte Antigen–associated Predisposition to Graves Disease (2021) (1)
- Functional Role and Mechanism of UCP2 Upregulation in Pancreatic ß Cells (2018) (1)
- Efficacy of the Self-management Support System DialBetesPlus for Diabetic Kidney Disease: Protocol for a Randomized Controlled Trial (Preprint) (2021) (0)
- SUSTAINable management of type 2 diabetes: feasibility of use and safety of semaglutide. (2018) (0)
- Author response for "Effects of 1‐year treatment with canagliflozin on body composition and total body water in patients with type 2 diabetes" (2021) (0)
- Genetically engineered models for type 2 diabetes (2006) (0)
- 2055-P: S100A8 Suppresses ß-Cell Proliferation in Diet-Induced Obese Mice (2020) (0)
- Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL) (2022) (0)
- 1497-P: Proinsulin as a Potential Marker of Early Pancreatic Beta-Cell Dysfunction (2019) (0)
- 2088-P: Soluble EGFR and Adipsin Are Independent Serum Biomarkers for Insulin Resistance in Mouse and Human (2019) (0)
- The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan. (2022) (0)
- Large-Scale Cross-Sectional Study of the Problem Areas in Diabetes Survey among Japanese Patients with Type 2 Diabetes Mellitus (2018) (0)
- Comparing the course and delivery outcomes of Japanese twin pregnancies with and without gestational diabetes mellitus: a single-center retrospective analysis. (2022) (0)
- ABBREVIATIONS MODY : maturation onset diabetes mellitus of the young MODY 2 : maturation onset diabetes mellitus of the young (2004) (0)
- 453-P: Diabetes Knowledge Test Score Predicts HbA1c Levels after Discharge in Inpatients with Type 2 Diabetes (2021) (0)
- 1619-P: Risk Factors for Sleep Apnea Syndrome in Nonobese Type 2 Diabetics (2019) (0)
- 113-LB: Effects of Liraglutide and Empagliflozin Add-On to Insulin Therapy in Patients with Type 2 Diabetes: ELLENA-IT, a Randomized Controlled Study (2019) (0)
- Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages (2018) (0)
- Review for "Safety and effectiveness of sean patients with type 2 diabetes mellitus: A post‐marketing surveillance study" (2020) (0)
- 3P-0712 Heterozygous PPAR γ deficient mice showed impaired endothelium-dependent vascular relaxation and increased neointima formation in response to cuff injury (2003) (0)
- [Disorder of insulin receptor-mediated signal transduction pathway]. (2011) (0)
- Role of the liver in glucose homeostasis in PI 3-kinase p85 (cid:1) -deficient mice (2009) (0)
- Efficacy of injection technique education in diabetes with lipohypertrophy: a systematic review and meta-analysis protocol v1 (0)
- Selective Ablation of IRS-1 Decreases Cardiac Contractility without Attenuating PAI-1 Expression or Perivascular Fibrosis (2003) (0)
- Efficacy of injection technique education in diabetes with lipohypertrophy: a systematic review and meta-analysis protocol v3 (0)
- Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study. (2020) (0)
- Differential roles of insulin and IGF-1 in murine keratinocyte differentiation (2000) (0)
- 2281-PUB: Quality of Life in Japanese Patients with Type 2 Diabetes Mellitus (2020) (0)
- Risk Factors for Sleep Apnea Syndrome in Diabetic Patients with a Focus on Comorbidities (2018) (0)
- Transgenic Approach to Insulin Signaling (2002) (0)
- 2. How to Select Anti-diabetic Drugs (2021) (0)
- Effects of Dulaglutide and Trelagliptin on Beta-Cell Function in Patients with Type 2 Diabetes—The DUET-Beta Study (2018) (0)
- [Knockout mouse models for type 2 diabetes. Mice with impaired insulin secretion]. (2002) (0)
- Abstract 4942: Identification of Insulin Receptor Substrate Family Proteins Mediating PAI-1 Production in Cardiac and Adipose Tissues From IRS-1 Null Mice (2006) (0)
- Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists (2022) (0)
- Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients (2014) (0)
- [Impaired glucose tolerance (IGT): current understanding and future research directions]. (2005) (0)
- Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study (2019) (0)
- The new basal insulin analog glargine U-300 enables flexible injection schedule. (2018) (0)
- Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study (2021) (0)
- Failure of compensatory beta-cell hyperplasia in response to insulin resistance plays a crucial role in the development of type 2 diabetes (2000) (0)
- PO139 DIFFERENT EFFECT OF SHORT-TERM AND LONG-TERM HIGH-FAT DIET FEEDING ON PANCREATIC BETA CELL PROLIFERATION (2014) (0)
- SAT-286 EFFECT OF DAPAGLIFLOZIN ON URINARY ALBUMIN EXCRETION AND HOME BLOOD PRESSURE PARAMETERS IN JAPANESE TYPE 2 DIABETES MELLITUS PATIENTS WITH ALBUMINURIA: Y-AIDA STUDY (2019) (0)
- Selective ablation of insulin receptor substrate-1 decreases cardiac contractility in vivo without attenuating PAI-1 expression or perivascular fibrosis (2003) (0)
- 460-P: Eating Behavior among Inpatients with Type 2 Diabetes (T2D) Is Affected by Childhood Food Education (2021) (0)
- Validity and reliability of the Japanese version of the diabetes knowledge test among in‐patients with type 2 diabetes (2021) (0)
- C-terminal globulardomäne of adiponectin for treatment of atherosclerosis (2003) (0)
- Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets (2017) (0)
- Abdominal aortic calcification is associated with morbidity of cardiovascular disease and Fib-4 index in type 2 diabetes: a retrospective cross-sectional study (2020) (0)
- Lack of Insulin Receptor Substrate-2 Is a Link between Insulin Resistance and an Increased Intima of the Vessel in Mice (2003) (0)
- 1903-P: Protective Effects of Linagliptin on Hepatic Steatosis in Mice Treated with Dual Inhibitor for Insulin Receptor and IGF-1 Receptor (2019) (0)
- Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306]. (2022) (0)
- Efficacy and Safety of Insulin Degludec and Insulin Glargine U-100 in Hospitalized Patients with Type 2 Diabetes—An Open-Label, Randomized Controlled Study (2018) (0)
- Equivalent Efficacy of Intensive Self-Monitoring of Blood Glucose to Real-Time Continuous Glucose Monitoring in Adults with Type 2 Diabetes (2018) (0)
- characterized by an impaired response to GP VI stimulation null platelets α Functional phenotype of phosphoinositide 3-kinase p85 (2003) (0)
- EFFECTS OF DAPAGLIFLOZIN IN HIGH AND LOW DIETARY SALT INTAKE PATIENTS WITH ALBUMINURIC DIABETIC KIDNEY DISEASE: A SUBANALYSIS OF THE Y-AIDA STUDY (2021) (0)
- [Postprandial hyperglycemia]. (2006) (0)
- PO309 LIMITATION OF THE DIAGNOSTIC SCREENING TOOL FOR NONALCOHOLIC STEATOHEPATITIS IN NON-OBESE JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2014) (0)
- Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study (2019) (0)
- Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906 (2017) (0)
- Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes (2022) (0)
- Approach to the Pathogenesis of Non-Insulin-Dependent Diabetes Mellitus by Gene Targeting. (1997) (0)
- Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study (2022) (0)
- Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (2016) (0)
- 780-P: Improved Mitochondrial Function by Luseogliflozin Prevents Pancreatic Beta-Cell Damage (2021) (0)
- 1855-P: Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice (2019) (0)
- Erratum to: Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin (2011) (0)
- [Molecular genetics of NIDDM]. (1997) (0)
- Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial. (2023) (0)
- Diagnostic accuracy of home sleep apnea testing using peripheral arterial tonometry for sleep apnea syndrome: protocol for a systematic review and meta-analysis v2 (2021) (0)
- Difference in Hepatic Steatosis and Pancreatic Beta-Cell Mass between Dapagliflozin and Insulin Glargine Treatment at Comparable Levels of Glycemic Control (2018) (0)
- [Aceruloplasminemia (hereditary ceruloplasmin deficiency) and diabetes mellitus]. (2006) (0)
- Kidney function assessment based on eGFR may broaden metformin eligibility rather than serum creatinine (2016) (0)
- [Genetic factors and life styles related to diabetes mellitus--with special reference to multiple factor inheritance]. (2000) (0)
- Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study (2023) (0)
- 994-P: Effects of Dulaglutide and Trelagliptin on ß-Cell Function after One Year in Patients with Type 2 Diabetes: DUET-Beta Extension Study (2019) (0)
- Relationship between Executive Functioning and Glycemic Controls in Patients with Type 2 Diabetes (2018) (0)
- Diabetic Nephropathy with Proteinuria Is the Risk of Indigestion Symptoms in Patients with Diabetes Mellitus—A Multicenter Survey in Japan (2018) (0)
- Association of continuous positive airway pressure therapy on cardiac hypertrophy in patients with sleep apnea comorbid with type 2 diabetes mellitus. (2022) (0)
- Review for "Safety and effectiveness of sean patients with type 2 diabetes mellitus: A post‐marketing surveillance study" (2020) (0)
- PJ-296 Heterozygous PPAR γ Deficient Mice Showed Increased Neointima Formation with Vascular Smooth Muscle Cell Proliferation in Response to Cuff Injury(Atherosclerosis, Basic 3 (IHD) : PJ50)(Poster Session (Japanese)) (2004) (0)
- Author response for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L" (2020) (0)
- Protective effects of S100A8 on sepsis mortality: Links to sepsis risk in obesity and diabetes (2022) (0)
- Vascular Intima Formation in Insulin Receptor Substrate-2 Deficient Mice (2002) (0)
- Author response for "Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?" (2021) (0)
- Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease (2021) (0)
- Analysis of the Effect of the Lowest SpO2 on Nocturnal Blood Glucose Fluctuation in Type 2 Diabetes Measured by WatchPAT and Continuous Glucose Monitoring (2018) (0)
- Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report (2021) (0)
- 2268-PUB: Relationship between Serum Free Fatty Acid and Proinsulin Concentrations (2020) (0)
- Efficacy of injection technique education in diabetes with lipohypertrophy: a systematic review and meta-analysis protocol v2 (0)
- OE-318 Maintenance of Cardiac and Adipose PAI-1 Expression Despite the Lack of IRS-1 : a Knockout Mouse Study(Diabetes/Obesity 2 (H) : OE40)(Oral Presentation (English)) (2004) (0)
- [Knockout mouse models for type 2 diabetes. Mice with insulin resistance]. (2002) (0)
- 2161-P: Overexpression of UCP2 in Pancreatic Beta Cells Caused Impaired Insulin Secretion through Mitochondrial Dysfunction and Aldolase B Expression (2019) (0)
- Effects of SGLT2 Inhibition on eGFR and Glomerular and Tubular Damage Markers in Japanese Patients With Type 2 Diabetes (2018) (0)
- Diminished Left Ventricular Function and Coronary Perivascular Fibrosis Associated with Insulin Resistance do not Require Insulin Receptor Substarte-1 Mediated Signaling (2002) (0)
- 2084-P: Hepatic Fat Accumulation Underlies the Inability of Glucokinase Activator to Achieve a Sustained Hypoglycemic Effect in db/db Mice (2020) (0)
- 1060-P: Effect of Dulaglutide and Long-Acting Insulin Combination Therapy in Patients with Type 2 Diabetes (2019) (0)
- A case of an elderly patient with insulin-dependent diabetes and dementia receiving one basal insulin plus one bolus insulin injections a day for 6 months (2020) (0)
- [Retinal-blood barrier]. (2010) (0)
- Influence of Insulin Receptor Substrate–2–Knockout on the Activity of Experimental Choroidal Neovascular in Mice Model (2006) (0)
- Evidence of brain atrophy detected on magnetic resonance imaging is associated with failure of acquisition of the ability for insulin self-injection. (2014) (0)
- A disproportionality analysis of the adverse effect profiles of methimazole and propylthiouracil in patients with hyperthyroidism using the Japanese Adverse Drug Event Report Database. (2023) (0)
- Sleep duration and food intake in people with type 2 diabetes mellitus and factors affecting confectionery intake (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yasuo Terauchi?
Yasuo Terauchi is affiliated with the following schools:
